Monday, 23 September 2019

World News

  • New commercial chief at Ra Pharma

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Ra Pharmaceuticals, a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, anno...Read more

  • J&J ramps up pricing for Imbruvica

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) conveniently ahead of research that suggests the drug, which costs ~$148...Read more

  • Mundipharma expands partnership with Caris Life Sciences

    World |  News | 0 Comment | 18 Apr, 2018

    Mundipharma is partnering with Caris Life Sciences, a leading US biotechnology company, to provide the exclusive sales, promotion, marketing and distribution of its tumor profiling service,...Read more

  • Novartis to invest $100M for malaria elimination

    World |  News | 0 Comment | 18 Apr, 2018

    Novartis has announced a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonweal...Read more

  • Sartorius Stedim Biotech, PSU announce partnership

    World |  News | 0 Comment | 18 Apr, 2018

    Sartorius Stedim Biotech and Penn State University (PSU) have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term re...Read more

  • GE launches new facility for viral vector based therapeutics

    World |  News | 0 Comment | 17 Apr, 2018

    GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene a...Read more

  • Shire offloads its oncology business for $2.4B

    World |  News | 0 Comment | 17 Apr, 2018

    Shire, a leading global biotechnology company focused on rare diseases is selling its oncology business to French drugmaker Servier S.A.S. for $2.4 billion. The US-based company said that t...Read more

  • Maternal metabolic factors and early-onset puberty may be related

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore - In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Northern California — maternal overweight and hyperglycemia were ...Read more

  • Major Italian sector federations showcase latest trends in healthcare

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore – Nine major Italian federations representing sectors from fashion to healthcare and technology, arrived in Singapore to promote the “Made In Italy” label. ...Read more

  • UK team develops novel skin patch for diabetes

    World |  News | 0 Comment | 13 Apr, 2018

    A group of scientists at the University of Bath has created a non-invasive adhesive patch that promises the measurement of glucose levels through the skin without carrying out the pain...Read more

  • Merck to accelerate global access to affordable vaccines

    World |  News | 0 Comment | 13 Apr, 2018

    Merck, a leading science and technology company has announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturi...Read more

  • Sanofi to invest in Canadian vaccine facility

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Sanofi is investing €350M (CAD $500M) to construct a new state-of-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. Th...Read more

  • Mylan, Biocon to launch Adalimumab Biosimilar in EU

    World |  News | 0 Comment | 13 Apr, 2018

    Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan’s in-licensing arrangement with Fujifilm Kyowa Kirin Biologics (FKB).  F...Read more

  • Boston Therapeutics poised to acquire MTA

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acquire MTA, a privately-held company dedicated to the development of nove...Read more

  • Abpro Therapeutics on deck for IPO

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Woburn, MA-based Abpro Therapeutics (ABP) has filed a preliminary prospectus for a $69M IPO. The preclinical-stage biotech firm develops next-generation anti...Read more

  • Capital raise for Vermillion

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- Vermillion, a bio-analytical solutions company focused on gynecologic disease, announced that it intends to offer shares of its common stock and convertible preferred stock in co...Read more

  • New study brings relief for travellers from leg swelling and jet lag

    World |  News | 0 Comment | 13 Apr, 2018

    Singapore- A new peer-reviewed, published study shows that natural French maritime pine bark extract Pycnogenol is effective in reducing lower leg swelling known as edema and relieving jet ...Read more

  • Abbott initiates groundbreaking study to treat CAD

    World |  News | 0 Comment | 12 Apr, 2018

    Singapore - Abbott announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging techno...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls